Skip to Content
Download Image

Biotech firm Blondin to collaborate on breast cancer research project in Finland

BIRMINGHAM, Alabama – A key executive for Blondin Bioscience LLC is a collaborator on a prestigious grant awarded by the Academy of Finland that will aid in the study of breast cancer therapies.

Dr. Katri Selander, founder and chief scientific officer of the Birmingham-based biotech startup, is a collaborator on the three-year, $474,000 grant awarded to Dr. Johanna Tuomela, who is with the University of Turku, one of the largest universities in Finland.

Dr. Tuomela studies the role of inflammasomes, a component of the innate immune system, and a protein called TLR9 in bisphosphonate responses in bone tissue and breast cancer. The grant may help identify patients that benefit most from bisphosphonates, a class of drugs that was initially used for osteoporosis but is now also used as adjuvant treatment in breast cancer.

Download Image

Aerojet Rocketdyne gives $1M for UAH Space Science Chair

Stay connected to what's happening in Alabama now.

  • Enter your email address to receive periodic updates on the evolution of business in Alabama.

Ready to start your company's next chapter in Alabama?

Alabama may be small in size, but its ability to accommodate businesses seeking success is vast. See why companies like Mercedes, Airbus, Hyundai, and Honda have decided to call Alabama home.

Find A Site Learn More About Alabama